Drug Helps Reduce Involuntary Movements for People with Huntington Disease

People with Huntington disease (HD) experienced fewer involuntary movements, also known as chorea,  while taking deutetrabenazine (SD-809) compared to placebo, according to a paper published today in the Journal of the American Medical Association (JAMA). This study was supported by University of Rochester Medical Center’s Clinical Trials Coordination Center, a unique academic-based organization with decades […]

Read the whole article on Science Blog

More from Science Blog